Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Myllia's Echoes of Silenced Genes: positive noise in CRISPR perturbation
Date 28 January 2026

Myllia's Echoes of Silenced Genes: positive noise in CRISPR perturbation

Introduction Myllia Biotechnology is a champion in merging bandwidth, CRISPR screening, and single-cell RNA sequencing. The company is popular as ‘Aelian Biotechnology’ along with its adv...

Lexicon's 'Get set go' attitude after entering Phase 3
Date 28 January 2026

Lexicon's 'Get set go' attitude after entering Phase 3

Introduction Lexicon Pharmaceuticals entered the competition in 1995 with its excellent small molecule drugs harnessed with gene knockout technology. The main target of the company is chronic issues ...

BMS, along with Janux, is ready to upgrade cancer drugs
Date 28 January 2026

BMS, along with Janux, is ready to upgrade cancer drugs

Introduction Bristol Myers Squibb (BMS), a leading biopharmaceutical company, aims to address immunology, cardiovascular, haematology, and oncology with its innovative and effective medicines, backed...

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia
Date 27 January 2026

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia

Introduction IntraBio Inc. operates in the healthy air of Austin, Texas, with its innovative treatment development for common and rare neurodegenerative conditions. The company sharpens its smartness...

Charles River and Gazi University to offer plasmid DNA together
Date 27 January 2026

Charles River and Gazi University to offer plasmid DNA together

Introduction Charles River Laboratories International, Inc., a well-known Contract Research Organisation (CRO), delivers fundamental services and products for government customers, academic space, bi...

Roche's Investment to redeem the obesity treatments
Date 27 January 2026

Roche's Investment to redeem the obesity treatments

Introduction Roche (F. Hoffmann-La Roche) is a multinational healthcare company that is a champion in merging diagnostics and pharmaceuticals to innovate treatments in immunology, infectious diseases...

J&J's eyes are on $100 billion
Date 27 January 2026

J&J's eyes are on $100 billion

Introduction Johnson & Johnson is a well-known company, recognised for its MedTech innovations and effective, innovative pharmaceuticals. Since 1886, the company has contributed to and advanced t...

 Supreme Court to Weigh Whether Federal Law Blocks Roundup Cancer Lawsuits
Date 23 January 2026

Supreme Court to Weigh Whether Federal Law Blocks Roundup Cancer Lawsuits

The U.S. Supreme Court said it will take up a closely watched case that could determine whether tens of thousands of people who claim the weedkiller Roundup caused their cancer will be allowed to purs...

Bayer Sues Pfizer, Moderna, BioNTech and J&J Over Alleged COVID-19 Vaccine Patent Infringement
Date 23 January 2026

Bayer Sues Pfizer, Moderna, BioNTech and J&J Over Alleged COVID-19 Vaccine Patent Infringement

Bayer has launched a new round of high-stakes patent litigation against the makers of several leading COVID-19 vaccines, alleging that they improperly used intellectual property originally developed b...

Tanabe's positive results bring life to EPP and XLP patients
Date 23 January 2026

Tanabe's positive results bring life to EPP and XLP patients

Introduction Tanabe Pharma America, Inc., formerly Mitsubishi Tanabe Pharma America, is a U.S. division of Japan’s Tanabe Pharma Corporation. The company is known for its marketing skills and i...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.